Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravenous iron.

× No keyword cloud information.

13 in total

1. Oh the irony: Iron as a cancer cause or cure?

Authors: Susan P Foy; Vinod Labhasetwar
Journal: Biomaterials Date: 2011-10-01 Impact factor: 12.479

2. Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors: Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal: Blood Date: 2010-06-16 Impact factor: 22.113

Review 3. Safety issues with intravenous iron products in the management of anemia in chronic kidney disease.

Authors: Amir Hayat
Journal: Clin Med Res Date: 2008-12

4. A link between premenopausal iron deficiency and breast cancer malignancy.

Authors: Jinlong Jian; Qing Yang; Yongzhao Shao; Deborah Axelrod; Julia Smith; Baljit Singh; Stephanie Krauter; Luis Chiriboga; Zhaoxu Yang; Jinqing Li; Xi Huang
Journal: BMC Cancer Date: 2013-06-24 Impact factor: 4.430

5. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.

Authors: Christoph Gasche; Tariq Ahmad; Zsolt Tulassay; Daniel C Baumgart; Bernd Bokemeyer; Carsten Büning; Stefanie Howaldt; Andreas Stallmach
Journal: Inflamm Bowel Dis Date: 2015-03 Impact factor: 5.325

6. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.

Authors: David Hetzel; William Strauss; Kristine Bernard; Zhu Li; Audrone Urboniene; Lee F Allen
Journal: Am J Hematol Date: 2014-06 Impact factor: 10.047

7. Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.

Authors: Lenar Yessayan; Ankur Sandhu; Anatole Besarab; Alexy Yessayan; Stan Frinak; Gerard Zasuwa; Jerry Yee
Journal: Int J Nephrol Date: 2013-03-18

Review 8. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy.

Authors: Alhossain A Khalafallah; Amanda E Dennis
Journal: J Pregnancy Date: 2012-06-26

9. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.

Authors: Saroj Vadhan-Raj; William Strauss; David Ford; Kristine Bernard; Ralph Boccia; Joe Li; Lee F Allen
Journal: Am J Hematol Date: 2013-09-30 Impact factor: 10.047

10. Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study.

Authors: Martha L Louzada; Cyrus C Hsia; Fatimah Al-Ani; Fiona Ralley; Anargyros Xenocostas; Janet Martin; Sarah E Connelly; Ian H Chin-Yee; Leonard Minuk; Alejandro Lazo-Langner
Journal: BMC Hematol Date: 2016-03-11